NYC's Top Hospital Under Antitrust Investigation: Price-Fixing Allegations

NewYork-Presbyterian, one of New York City's leading hospital systems, is under investigation by the Justice Department for potential antitrust violations. The investigation centers around accusations of hidden deals with insurance companies that allegedly kept hospital prices artificially high.

<img src="https://static01.nyt.com/images/2025/07/25/multimedia/00met-antitrust-hospital-01-wgqm/00met-antitrust-hospital-01-wgqm-articleLarge.jpg?quality=75&amp;auto=webp&amp;disable=upscale" alt="NewYork-Presbyterian Hospital Building">

The investigation focuses on the negotiations between hospitals and insurers, a previously under-scrutinized area of antitrust enforcement. The probe seeks to determine if NewYork-Presbyterian used tactics to insulate itself from competition, allowing it to charge higher prices for procedures like childbirth, knee replacements, and colonoscopies.

Union's Role in Triggering Investigation

A key factor in launching the investigation was a memo from Local 32BJ of the Service Employees International Union, representing 90,000 NYC workers. The union had long complained about NewYork-Presbyterian's high prices and alleged anti-competitive behavior.

<img src="https://static01.nyt.com/images/2025/07/25/multimedia/00met-antitrust-hospital-02-wgqm/00met-antitrust-hospital-02-wgqm-articleLarge.jpg?quality=75&amp;auto=webp&amp;disable=upscale" alt="Union President Manny Pastreich protesting">

The union's memo detailed NewYork-Presbyterian's attempts to block efforts to steer union members to lower-cost hospitals. The union even temporarily implemented higher co-payments for members using NewYork-Presbyterian, resulting in significant cost savings before encountering obstacles.

Potential Impact and Further Investigation

This investigation could lead to increased competition among NYC hospitals and potentially lower healthcare costs for patients. Experts believe that many leading hospital systems engage in similar secretive anti-competitive practices with insurers. The investigation’s outcomes could unveil the complexities and secrecy of hospital-insurer negotiations, affecting how healthcare networks are structured and negotiated.

The investigation is still ongoing, and no wrongdoing has been confirmed. However, the implications for the healthcare industry and patient costs in New York City are significant.